🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To evaluate the safety, tolerability and efficacy of SHR-A1811 in combinati...
Status
Unknown
Location
Jiangsu Provincial People's Hospital
Start Date
2022-05-23
Trial ID
NCT05353361
Treatments Being Tested
To evaluate the efficacy and safety of SHR-A1811 with or without pertuzumab...
Status
Active Not Recruiting
Location
The First Affiliated Hospital of Nanjing Medical University
Start Date
2023-10-16
Trial ID
NCT06057610
This prospective, response-guided phase II study investigates individualize...
Status
Recruiting
Location
2nd Affiliated Hospital, School of Medicine, Zhejiang University
Start Date
2025-12-25
Trial ID
NCT07340398
Treatments Being Tested
This study evaluates HER2-PET/CT-guided dynamic optimization of neoadjuvant...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-05-01
Trial ID
NCT07527806
The study is being conducted to evaluate the efficacy, safety, and ORR of H...
Status
Recruiting
Location
Cancer Hospital Chinese Academy of Medical Science
Start Date
2025-10-28
Trial ID
NCT07140393
This is a prospective, single-center, randomized controlled phase II clinic...
Status
Not Yet Recruiting
Location
First Affiliated Hospital of Nanjing Medical Unviersity
Start Date
2026-07-16
Trial ID
NCT07716111
This is a multicenter, two-arm, exploratory clinical study designed to eval...
Status
Not Yet Recruiting
Location
The Fourth Hospital of Hebei Medical University
Start Date
2026-05
Trial ID
NCT07528898
Treatments Being Tested
Breast cancer is the most common malignancy in women, with approximately 20...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-12-20
Trial ID
NCT07307287
Treatments Being Tested
The study enrolled patients with advanced or metastatic NSCLC harboring HER...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-02-15
Trial ID
NCT07377916
Treatments Being Tested
The purpose of this study is to establish a prospective, single-center plat...
Status
Recruiting
Location
Fudan University Shanghai Cancer Center Shanghai, China, 200032
Start Date
2022-11-01
Trial ID
NCT05582499
Treatments Being Tested